- Limb salvage, endovascular and open procedures for Peripheral Artery Disease (PAD), diabetic
foot ulcers.
- Open and endovascular repair of Aortic Aneurysms and Dissections.
- Stroke Prevention, TCAR, carotid endarterectomy and carotid stenting.
- Thoracic Aortic Aneurysm repair, open and endovascular.
- Catheter based procedures for Deep Vein Thrombosis (DVT) and other venous diseases
- Hemodialysis access and maintenance.
- Office based procedures for varicose veins and spider veins
Hospital Affiliation
University Hospital, Newark
Insurance Participation
Insurance Participation: with Provider Number (where applicable) The information below is subject to change and should not be relied upon until after
it is verified with the insurance company. In addition, psychiatric providers should
be contacted directly for information on their participation with managed care and
insurance companies.
Dr. Saqib Zia is an Associate Professor of Surgery in the Division of Vascular Surgery at Rutgers New
Jersey Medical School and serves as Program Director of the Vascular Surgery Fellowship and Integrated
Residency. He is also Chief of Vascular Surgery at the VA New Jersey Healthcare System, where he leads
a growing, high-acuity vascular program dedicated to delivering advanced care to veterans.
Dr. Zia completed his medical education at King Edward Medical University, followed by Basic Surgical
Training at Whipps Cross University Hospital in London, United Kingdom, where he earned Membership in
the Royal College of Surgeons of England. He pursued further surgical training in the United States,
completing his general surgery internship at the University of Virginia and residency at the University of
Wisconsin-Madison. He subsequently completed a fellowship in vascular and endovascular surgery at
Staten Island University Hospital.
Prior to joining Rutgers NJMS, Dr. Zia served as an Assistant Professor of Surgery at the Zucker School of
Medicine at Hofstra/Northwell, where he developed a high-volume vascular surgery practice. He is board
certified by the American Board of Surgery in both General Surgery and Vascular Surgery, is a Fellow of
the American College of Surgeons, and holds certification as a Registered Physician in Vascular
Interpretation (RPVI).
At Rutgers NJMS, Dr. Zia has played a pivotal leadership role in advancing surgical education. As
Program Director, he successfully led the initial ACGME accreditation of an integrated vascular surgery
residency program, complementing the institution's well-established fellowship. This effort has resulted in
the development of one of the largest and most comprehensive vascular surgery training programs in New
Jersey.
In his role at the East Orange VA Medical Center as Chief of Vascular Surgery, Dr. Zia has led the
transformation of vascular services by establishing a modern, comprehensive program focused on cutting-
edge endovascular and open surgical therapies. He is actively involved in regional and national
committees and has authored numerous peer-reviewed publications, reflecting his commitment to
academic excellence, education, and innovation in vascular surgery.
Education
MD, 2001, King Edward Medical University BS, 1995, Forman Christian College
Licensure & Certification
Medical Licensure New Jersey
Languages
Hindi Punjabi Urdu
Relevant Publications
Panse NS, Mina GE, Yu Y, Huang J, Padberg FT, Zia S, Latif W, Curi MA.
Arteriovenous Fistula Creation and Care in an Office-Based Practice Compared to
Hospital Based Care. J Vasc Surg. 2025 May;81(5):1193-1200.e2. doi:
10.1016/j.jvs.2025.01.002. Epub 2025 Jan 10
PMID: 39800116
Mohannad B. Bisharat, Eugene J. Ichinose, Kalyan K. Veerina, Vipul Khetarpaul,
Ezana M. Azene, Adam N. Plotnik, Jeffrey Hnath, Eric Trestman, Stuart A. Harlin,
Ambarish Bhat, Shuo Li, Graham W. Long, David O'Connor, Ronald S. Winokur,
Saqib Zia, David J. Dexter, One-Year Clinical Outcomes Following Mechanical
Thrombectomy for Deep Vein Thrombosis: A CLOUT Registry Analysis. J Soc
Cardiovasc Angiogr Interv. 2024 Feb 15;3(3Part A):101307.
PMID: 39131784
CLOUT study collaborators. Mechanical Thrombectomy vs. Pharmacomechanical
Catheter Directed Thrombolysis for the Treatment of Iliofemoral Deep Vein
Thrombosis: A Propensity Score Matched Exploratory Analysis of 12 Month Clinical
Outcomes. Eur J Vasc Endovasc Surg. 2024 Apr;67(4):644-652
PMID: 37981003
Patel P, Yu Y, Zia S, Padberg F, Curi M, Huang J. Systemic Thrombolysis as Initial
Treatment of COVID-19 Associated Acute Aortoiliac and Lower Extremity Arterial
Thrombosis. Ann Vasc Surg. 2021 Jan;70:297-301. doi: 10.1016/j.avsg.2020.08.083.
Epub 2020 Aug 28. PMID: 32861850; PMCID: PMC7453212
Zia S, Juneja A, Shams S, Faheem B, Shariff M, Singh K, Schor J, Deitch J.
Contemporary Outcomes of Infrapopliteal Atherectomy versus Balloon Angioplasty
Alone for Critical Limb Ischemia. Zia S, Juneja A, Shams S, Faheem B, Shariff MA,
Singh K, Schor J, Deitch J. J Vasc Surg. 2020 Jun;71(6):2056-2064. doi:
10.1016/j.jvs.2019.08.254. Epub 2019 Nov 11. PMID: 31727459
Singh K, Juneja A, Bajaj T, Voto C, Schor J, Zia S, Deitch J. Single Tertiary Care
Center Outcomes After Lower Extremity Cadaveric Vein Bypass for Limb Salvage.
Vasc Endovascular Surg. 2021 Feb;55(2):204. doi: 10.1177/1538574420966452. Epub
2020 Oct 29. PMID: 33118465
Juneja A, Zia S, Ayad MH, Singh K, Dietch J, Schor J. Safety and Feasibility of Performing
Fenestrated Endovascular Abdominal Aneurysm Repair Using a Portable C-arm Without Fusion
Technology: A Single-Center Experience. Cureus. 2020 Apr 20;12(4):e7739. doi:
10.7759/cureus.7739. PMID: 32455059
Zia S, Simons J, Woo K, Rathbun J, Ryan P. Merit-Based incentive payment system year 3 quality
reporting options. J Vasc Surg. 2019 Jul;70(1):327. doi: 10.1016/j.jvs.2019.04.463. PMID: 31230650
Managing Central Venous Access during a Healthcare Crisis- J Vasc Surg. 2020
Oct;72(4):1184-1195.e3. doi: 10.1016/j.jvs.2020.06.112. Epub 2020 Jul 15 PMID:
32682063
Guerges M, Zia S. Endovascular Repair of Carotid Artery Pseudoaneurysm using
Transcarotid Artery Revascularization Flow Reversal Technique. Ann Vasc Surg.
2020 Jul;66:668.e11-668.e14. doi: 10.1016/j.avsg.2019.12.024. Epub 2020 Jan 9.
PMID: 31926273
Course List
A. PrincipalInvestigator
1. ClotTriever Outcomes (CLOUT) Registry. Rutgers New Jersey Medical School. April
2021
2. GORE Educational Grant for Vascular Surgery Fellowship. Rutgers New Jersey
8
Medical School. April 2021. $10,000
3. 19-0334-SIUHN ClotTriever Outcomes (CLOUT) Registry. Staten Island University
Hospital North 2019. $61,950
4. 18-0204-SIUHN Bard?? LifeStent?? Popliteal Artery Stent Project. Staten Island
University Hospital North 2018. $1,700
5. Medtronic Aortic Fellow Travel Grant Feb 2024- $12,000
6. InnAVasc CSP-2022- Sponsored by W.L. Gore & Associates, Inc. March 2024-
This study will evaluate the safety and effectiveness of the InnAVasc
arteriovenous graft (AVG) when implanted in and used for hemodialysis in
participants suffering from end-stage renal failure (ESRD)
B. Co-Investigator
1. Humacyte CLN-PRO-V007: Phase 3, prospective, multicenter, open-label, randomized,
two-arm, comparative study. Subjects with end-stage renal disease (ESRD) randomized
to receive either a human acellular vessel (HAV) or arteriovenous fistula (AVF).
Rutgers- New Jersey Medical School. Enrolling since August 2017.
2. IMPROVE-AD- IMPRoving Outcomes in Vascular DisEase Aortic Dissection
To compare clinical outcomes in patients with a type B aortic dissection that undergo
thoracic endovascular aortic repair (TEVAR) and medical therapy vs. a strategy of
medical therapy with standard of care surveillance for deterioration. National Heart,
Lung and Blood Institute
3. Humacyte CLN-PRO-V012 A Phase 3 Open-Label, Sponsor-Blinded Study to Compare
the Efficacy and Safety of the Humacyte Human Acellular Vessel (HAV) with that of
an Autogenous Arteriovenous Fistula (AVF) in Female Patients with End-Stage Renal
Disease Requiring Hemodialysis
4. Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual
vascular Risk (LEADER-PAD): A randomized trial
5. CLN-PRO-V005. A Phase 2 Study for the Evaluation of Safety and Efficacy of
Humacyte???s Human Acellular Vessel for Use as a Vascular Bypass or Interposition
Vessel in Patients with Limb-threatening Peripheral Arterial Trauma. Rutgers- New
Jersey Medical School. Enrolling since January 2018.
6. 18-0091-SIUHN Chronic Venous Thrombosis: Relief with Adjunctive CatheterDirected Therapy: The
C-Tract Trial. (The C-TRACT Trial) (C-TRACT),
ClinicalTrial.gov -NCT03250247 2018. $10,500.
7. 15-093-SIUHN Trial to Compare Best Endovascular versus Best Surgical Therapy in
Patients with Critical Limb Ischemia (BEST-CLI) 2015. $12,000
8. 16-883-SIUHN. RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston
Scientific RANGER??? Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal
Arteries(PPA). 2016. $10,601
9. 17-0625-SIUHN A Prospective, Multi-Center, Single-Arm, Real-World Study
Assessing the Clinical Use of the Bard?? UltraScore??? Focused Force PTA Balloon.
2017. $27,274
10. HS15-0561-SIUHN Assessment of the GORE?? EXCLUDER?? Conformable AAA
Endoprosthesis(CEXC Device) in the Treatment of Abdominal Aortic Aneurysms.
2015. $12,112
